TRH and acquired polycythemia vera: Although thyroid dysfunction was an exclusion criterion in the study, the significant elevation of thyrotropin-releasing hormone (TRH) (16.72-fold) in PV patients is an unexpected finding, as thyroid dysfunction in hematological malignancies is typically attributed to autoimmune or iatrogenic causes rather than primary neuroendocrine dysregulation [43].